{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:31Z","timestamp":1792036291660,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.nbd.2013.03.013","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T15:12:45Z","timestamp":1364829165000},"page":"37-43","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression"],"prefix":"10.1016","volume":"55","author":[{"given":"Valerio","family":"Leoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2013.03.013_bb0005","series-title":"Second International Symposium on Information Theory","article-title":"Information theory as an extension of the maximum likelihood principle","author":"Akaike","year":"1973"},{"key":"10.1016\/j.nbd.2013.03.013_bb0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainresbull.2006.10.028","article-title":"Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease","volume":"72","author":"Aylward","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2013.03.013_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2013.03.013_bb0020","author":"Bates"},{"key":"10.1016\/j.nbd.2013.03.013_bb0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bj\u00f6rkhem","year":"2006","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.nbd.2013.03.013_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mam.2009.02.001","article-title":"Oxysterols and neurodegenerative diseases","volume":"30","author":"Bj\u00f6rkhem","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.nbd.2013.03.013_bb0035","series-title":"Hopkins Verbal Learning Test \u2014 Revised: Professional Manual","author":"Brandt","year":"1991"},{"key":"10.1016\/j.nbd.2013.03.013_bb0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-2275(20)32393-2","article-title":"Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface","volume":"41","author":"Bretillon","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2013.03.013_bb0045","series-title":"Model selection and multi-model inference: a practical information-theoretic approach","author":"Burnham","year":"2002"},{"key":"10.1016\/j.nbd.2013.03.013_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1467-9868.2004.00438.x","article-title":"Likelihood ratio tests in linear mixed models with one variance component","volume":"66","author":"Crainiceanu","year":"2004","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"10.1016\/j.nbd.2013.03.013_bb0060","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"issue":"2 Pt 1","key":"10.1016\/j.nbd.2013.03.013_bb0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1288\/00005537-198402000-00004","article-title":"University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic","volume":"94","author":"Doty","year":"1984","journal-title":"Laryngoscope"},{"key":"10.1016\/j.nbd.2013.03.013_bb0070","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/122.9.1667","article-title":"Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease","volume":"122","author":"Harris","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2013.03.013_bb0075","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.22485","article-title":"Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease","volume":"24","author":"Henley","year":"2009","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.nbd.2013.03.013_bb0080","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A2018","article-title":"Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study","volume":"31","author":"Hobbs","year":"2010","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.nbd.2013.03.013_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom. J."},{"issue":"3","key":"10.1016\/j.nbd.2013.03.013_bb0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0309-253","article-title":"Getting a handle on Huntington's disease: the case for cholesterol","volume":"15","author":"Katsuno","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2013.03.013_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neulet.2004.07.031","article-title":"Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients","volume":"368","author":"Kolsch","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.nbd.2013.03.013_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","article-title":"CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches","volume":"153B","author":"Langbehn","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.nbd.2013.03.013_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biochi.2012.09.025","article-title":"24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases","volume":"95","author":"Leoni","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.nbd.2013.03.013_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(02)00887-X","article-title":"Changes in human plasma levels of 24S-hydroxycholesterol during progression of multiple sclerosis","volume":"331","author":"Leoni","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2013.03.013_bb0115","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nbd.2013.03.013_bb0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","article-title":"Whole body cholesterol metabolism is impaired in Huntington's disease","volume":"494","author":"Leoni","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.nbd.2013.03.013_bb0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1025897811143","article-title":"Confounding due to cluster in multicenter studies \u2014 causes and cures","volume":"3","author":"Localio","year":"2002","journal-title":"Health Serv. Outcomes Res. Methodol."},{"key":"10.1016\/j.nbd.2013.03.013_bb0130","series-title":"Longitudinal Data Analysis for the Behavioral Sciences Using R","author":"Long","year":"2012"},{"key":"10.1016\/j.nbd.2013.03.013_bb0135","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","article-title":"cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain","volume":"6","author":"Lund","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"25","key":"10.1016\/j.nbd.2013.03.013_bb0140","doi-asserted-by":"crossref","first-page":"22980","DOI":"10.1074\/jbc.M303415200","article-title":"Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover","volume":"278","author":"Lund","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2013.03.013_bb0145","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","article-title":"Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation","volume":"93","author":"L\u00fctjohann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.03.013_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0895-6111(02)00011-3","article-title":"Structural MR image processing using the BRAINS2 toolbox","volume":"26","author":"Magnotta","year":"2002","journal-title":"Comput. Med. Imaging Graph."},{"issue":"9","key":"10.1016\/j.nbd.2013.03.013_bb0160","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1176\/appi.ajp.2007.06081266","article-title":"Morphology of the cerebral cortex in preclinical Huntington's disease","volume":"164","author":"Nopoulos","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"Pt. 1","key":"10.1016\/j.nbd.2013.03.013_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/brain\/awq280","article-title":"Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment","volume":"134","author":"Nopoulos","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2013.03.013_bb0170","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","article-title":"Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease","volume":"11","author":"Papassotiropoulos","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2013.03.013_bb0175","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington's disease decades before diagnosis, the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.nbd.2013.03.013_bb0180","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington's disease","volume":"41","author":"Penney","year":"1997","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2013.03.013_bb0185","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuroimage.2010.06.047","article-title":"Fully automated analysis using BRAINS: AutoWorkup","volume":"54","author":"Pierson","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2013.03.013_bb0190","series-title":"Mixed-effects Models in S and S-PLUS","author":"Pinheiro","year":"2000"},{"key":"10.1016\/j.nbd.2013.03.013_bb0050","series-title":"R: A Language and Environment For Statistical Computing","isbn-type":"print","author":"R Core Team","year":"2013","ISBN":"https:\/\/id.crossref.org\/isbn\/3900051070"},{"issue":"1","key":"10.1016\/j.nbd.2013.03.013_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2013.03.013_bb0200","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1037\/a0018905","article-title":"Self-paced timing detects and tracks change in prodromal Huntington disease","volume":"24","author":"Rowe","year":"2010","journal-title":"Neuropsychology"},{"key":"10.1016\/j.nbd.2013.03.013_bb0205","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","article-title":"Cholesterol in Alzheimer's disease","volume":"4","author":"Shobab","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2013.03.013_bb0210","series-title":"Symbol Digit Modalities Test (SDMT). Manual (revised)","author":"Smith","year":"1982"},{"key":"10.1016\/j.nbd.2013.03.013_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2009.06.073","article-title":"Plasma levels of 24-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease","volume":"462","author":"Solomon","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2013.03.013_bb0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"28","author":"Stroop","year":"1935","journal-title":"J. Exp. Psychol."},{"issue":"2","key":"10.1016\/j.nbd.2013.03.013_bb0225","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency","volume":"11","author":"The Huntington Study Group","year":"1996","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.nbd.2013.03.013_bb0235","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nbd.2013.03.013_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00228-005-0068-9","article-title":"Effect of pravastatin on plasma sterols and oxysterols in men","volume":"62","author":"Thelen","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.nbd.2013.03.013_bb0245","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.03.013_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington's disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.03.013_bb0260","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2013.03.013_bb0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2013.03.013_bb0270","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2013.03.013_bb0275","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2013.03.013_bb0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2013.03.013_bb0285","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","article-title":"Development of biomarkers for Huntington's disease","volume":"10","author":"Weir","year":"2011","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2013.03.013_bb0290","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ajmg.b.31232","article-title":"Indexing disease progression at study entry with individuals at-risk for Huntington disease","volume":"156B","author":"Zhang","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.nbd.2013.03.013_bb0295","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1017\/S1355617707071214","article-title":"fMRI detection of early neural dysfunction in preclinical Huntington's disease","volume":"13","author":"Zimbelman","year":"2007","journal-title":"J. Int. Neuropsychol. Soc."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T19:43:48Z","timestamp":1644695028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996113001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":56,"alternative-id":["S0969996113001010"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2013.03.013","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}